PrenatalSafe® is a non-invasive prenatal screening test that analyzes fetal DNA from a maternal blood sample.

This test screens for chromosomal abnormalities, including trisomies (e.g., Down syndrome), microdeletions, and structural variations.

– Safe and non-invasive, starting from the 10th week of pregnancy.
– Nine levels of analysis for detailed insights.

From the10th week of pregnancy.

GeneSafe® is a non-invasive genetic test that detects both inherited and de novo genetic conditions in the fetus.

Available in three levels to meet specific needs:

– Inherited: Screens for hereditary conditions.

– De novo: Detects new genetic variations.

– Complete: Combines both inherited and de novo analysis.

Performed from the 10th week of pregnancy for early insight.

A comprehensive newborn screening test to detect early-onset genetic conditions.

Uses Next-Generation Sequencing (NGS) to screen over 280 conditions.

Focuses on various clinical areas to allow early intervention, ensuring improved health outcomes for newborns.

Endometrial Receptivity Test

Assesses the endometrium’s readiness for embryo implantation, critical for IVF success.

– Analyzes genes related to endometrial health.
– Identifies the optimal implantation window.structural variations.

Especially useful for patients undergoing IVF, improving implantation success rates.

Preimplantation Genetic Testing

– PGT-A: Invasive option involving embryo biopsy.

– niPGT-A: Non-invasive, using cell-free DNA from culture medium.

Screens embryos for chromosomal abnormalities before implantation structural variations.

Increases IVF success rates by identifying the most viable embryos.

Carrier Screening

Carrier screening test that identifies genetic variants linked to inherited disorders.

Provides prospective parents with critical insights into carrier status, helping them assess potential genetic risks for future children.structural variations.

GeneScreen™ offers customizable screening options tailored to individual family planning needs.